Additionally, elevated MALAT1 expression was associated with a significant decrease in disease-free survival in COAD, Liver Hepatocellular Carcinoma (LIHC), and Prostate Adenocarcinoma (PRAD). Here, MALAT1 is linked to colon adenocarcinoma.